Position in PFE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,798,511
-$432,473 QoQ
Shares Held
74,689
-6.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,011
of 2,821 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VestGen Advisors, LLC holds $52,277,450 across 13 Drug Manufacturers - General names. PFE ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,771 | $15,317,921 | |
| 2 | ABBV |
AbbVie Inc.
|
47,682 | $11,998,698 | |
| 3 | JNJ |
Johnson & Johnson
|
35,531 | $9,023,808 | |
| 4 | MRK |
Merck & Co., Inc.
|
32,161 | $4,132,688 | |
| 5 | AMGN |
Amgen Inc
|
7,473 | $2,706,122 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
18,631 | $2,353,840 | |
| 7 | PFE |
Pfizer Inc
This page
|
74,689 | $1,798,511 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
30,225 | $1,741,564 |
All Filings in PFE
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,798,511 | 74,689 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $2,230,984 | 79,451 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,667,378 | 66,963 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,651,944 | 64,833 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $930,816 | 38,400 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $944,599 | 37,277 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||